LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity.

Excess lipid accumulation is an early signature of nonalcoholic fatty liver disease (NAFLD). Although liver receptor homolog 1 (LRH-1) (encoded by NR5A2) is suppressed in human NAFLD, evidence linking this phospholipid-bound nuclear receptor to hepatic lipid metabolism is lacking. Here, we report an essential role for LRH-1 in hepatic lipid storage and phospholipid composition based on an acute hepatic KO of LRH-1 in adult mice (LRH-1AAV8-Cre mice). Indeed, LRH-1-deficient hepatocytes exhibited large cytosolic lipid droplets and increased triglycerides (TGs). LRH-1-deficient mice fed high-fat diet displayed macrovesicular steatosis, liver injury, and glucose intolerance, all of which were reversed or improved by expressing wild-type human LRH-1. While hepatic lipid synthesis decreased and lipid export remained unchanged in mutants, elevated circulating free fatty acid helped explain the lipid imbalance in LRH-1AAV8-Cre mice. Lipidomic and genomic analyses revealed that loss of LRH-1 disrupts hepatic phospholipid composition, leading to lowered arachidonoyl (AA) phospholipids due to repression of Elovl5 and Fads2, two critical genes in AA biosynthesis. Our findings reveal a role for the phospholipid sensor LRH-1 in maintaining adequate pools of hepatic AA phospholipids, further supporting the idea that phospholipid diversity is an important contributor to healthy hepatic lipid storage.

[1]  T. Lüscher,et al.  Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease , 2017, The Journal of clinical investigation.

[2]  J. Borlak,et al.  Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. , 2016, Translational research : the journal of laboratory and clinical medicine.

[3]  R. Coleman,et al.  SEIPIN Regulates Lipid Droplet Expansion and Adipocyte Development by Modulating the Activity of Glycerol-3-phosphate Acyltransferase , 2016, Cell reports.

[4]  P. Griffin,et al.  Crystal Structures of the Nuclear Receptor, Liver Receptor Homolog 1, Bound to Synthetic Agonists*♦ , 2016, The Journal of Biological Chemistry.

[5]  E. Gratton,et al.  Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet. , 2016, Cell metabolism.

[6]  J. Maher,et al.  Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury. , 2016, The Journal of nutritional biochemistry.

[7]  B. Staels,et al.  Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease. , 2016, Annual review of physiology.

[8]  J. Borén,et al.  Liver receptor homolog‐1 is a critical determinant of methyl‐pool metabolism , 2016, Hepatology.

[9]  A. Deacon,et al.  Structure of Liver Receptor Homolog-1 (NR5A2) with PIP3 hormone bound in the ligand binding pocket. , 2015, Journal of structural biology.

[10]  R. Fletterick,et al.  A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver , 2015, eLife.

[11]  A. Burt,et al.  Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management. , 2015, Journal of hepatology.

[12]  H. Kiyonari,et al.  Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport , 2015, eLife.

[13]  E. Gratton,et al.  Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion , 2015, eLife.

[14]  Richard P. Bazinet,et al.  Polyunsaturated fatty acids and their metabolites in brain function and disease , 2014, Nature Reviews Neuroscience.

[15]  A. Deacon,et al.  The signaling phospholipid PIP3 creates a new interaction surface on the nuclear receptor SF-1 , 2014, Proceedings of the National Academy of Sciences.

[16]  E. Vassilatou Nonalcoholic fatty liver disease and polycystic ovary syndrome. , 2014, World journal of gastroenterology.

[17]  W. Martinet,et al.  Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. , 2014, World journal of gastroenterology.

[18]  D. Silver,et al.  Recent advances in understanding proteins involved in lipid droplet formation, growth and fusion. , 2014, Journal of genetics and genomics = Yi chuan xue bao.

[19]  P. Edwards,et al.  LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. , 2013, Cell metabolism.

[20]  D. Silver,et al.  The Lipid Droplet as a Potential Therapeutic Target in NAFLD , 2013, Seminars in Liver Disease.

[21]  P. Bedossa,et al.  A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. , 2013, Journal of hepatology.

[22]  P. Griffin,et al.  Divergent Sequence Tunes Ligand Sensitivity in Phospholipid-regulated Hormone Receptors* , 2013, The Journal of Biological Chemistry.

[23]  Robert V Farese,et al.  Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. , 2013, Developmental cell.

[24]  Jonathan C. Cohen,et al.  Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis. , 2012, The Journal of clinical investigation.

[25]  Zhong-hai Yan,et al.  Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern. , 2012, Gene.

[26]  J. Auwerx,et al.  LRH-1-dependent glucose sensing determines intermediary metabolism in liver. , 2012, The Journal of clinical investigation.

[27]  P. Li,et al.  Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites , 2011, The Journal of cell biology.

[28]  Robert V Farese,et al.  Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. , 2011, Cell metabolism.

[29]  Scott A. Busby,et al.  A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects , 2011, Nature.

[30]  Richard J Whitby,et al.  Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). , 2011, Journal of medicinal chemistry.

[31]  D. Vance,et al.  Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis , 2010, Hepatology.

[32]  J. R. Prigge,et al.  Cre activity in fetal albCre mouse hepatocytes: Utility for developmental studies , 2009, Genesis.

[33]  Takao Shimizu,et al.  Acyl-CoA:Lysophospholipid Acyltransferases* , 2009, Journal of Biological Chemistry.

[34]  S. Kliewer,et al.  Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. , 2008, Molecular endocrinology.

[35]  Takao Shimizu,et al.  Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity , 2008, Proceedings of the National Academy of Sciences.

[36]  R. Wade,et al.  Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia* , 2007, Journal of Biological Chemistry.

[37]  Shelly C. Lu,et al.  Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice , 2007, Hepatology.

[38]  Michelle M Wiest,et al.  A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.

[39]  J. Auwerx,et al.  Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1 , 2007, Molecular and Cellular Biology.

[40]  Janet Hager,et al.  Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP , 2005, Nature Structural &Molecular Biology.

[41]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[42]  R. Hammer,et al.  Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Willson,et al.  Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1 , 2005, Cell.

[44]  Jay D. Horton,et al.  Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver* , 2004, Journal of Biological Chemistry.

[45]  J. Breslow,et al.  Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  N. Wolins,et al.  Adipocyte Protein S3-12 Coats Nascent Lipid Droplets* , 2003, Journal of Biological Chemistry.

[47]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[48]  G. Gil,et al.  Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription. , 2000, The Journal of biological chemistry.

[49]  Richard D. Gregg,et al.  Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Hellerstein,et al.  Measurement of de novo hepatic lipogenesis in humans using stable isotopes. , 1991, The Journal of clinical investigation.

[51]  R. Fletterick,et al.  Structure of SF-1 bound by different phospholipids: evidence for regulatory ligands. , 2009, Molecular endocrinology.

[52]  D. L. Cinti,et al.  The fatty acid chain elongation system of mammalian endoplasmic reticulum. , 1992, Progress in lipid research.